Tenoxicam

替诺昔康

Report date: 2022/09/07 17:52:01
NME

Base Information

Drug NameTenoxicam
Drug Alias Name噻吩喜康tenoxicamum噻吩昔康tenoxicam替洛昔康 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesCollege of Pharmaceutical Sciences Zhejiang UniversityHangzhou Desheng Pharmaceutical Technology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeM01AC02
Related LinksWikipediaDrugBankKEGG